Login / Signup

Neoadjuvant chemotherapy with FOLFOX4 regimen to treat advanced gastric cancer improves survival without increasing adverse events: a retrospective cohort study from a Chinese center.

Zhen SunRui-Juan ZhuGui-Fang YangYan Li
Published in: TheScientificWorldJournal (2014)
The FOLFOX4 neoadjuvant chemotherapy could improve survival without increasing adverse events in patients with AGC.
Keyphrases
  • neoadjuvant chemotherapy
  • locally advanced
  • lymph node
  • sentinel lymph node
  • metastatic colorectal cancer
  • free survival
  • squamous cell carcinoma
  • radiation therapy